Home > Compound List > Compound details
302-53-4 molecular structure
click picture or here to close

3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid

ChemBase ID: 103979
Molecular Formular: C10H14N2O4
Molecular Mass: 226.22916
Monoisotopic Mass: 226.09535694
SMILES and InChIs

SMILES:
CC(Cc1cc(O)c(O)cc1)(NN)C(=O)O
Canonical SMILES:
NNC(C(=O)O)(Cc1ccc(c(c1)O)O)C
InChI:
InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)
InChIKey:
TZFNLOMSOLWIDK-UHFFFAOYSA-N

Cite this record

CBID:103979 http://www.chembase.cn/molecule-103979.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
IUPAC Traditional name
@carbidopa
carbidopa
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
Synonyms
(S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid
S-(-)-α-Hydrazino-3,4-dihydroxy-2-methylbenzenepropanoic acid
S-(-)-Carbidopa
α-Hydrazino-3,4-dihydroxy-α-methyl-benzenepropanoic Acid
DL-α-Hydrazino-3,4-dihydroxy-α-methylhydrocinnamic Acid
α-Hydrazino-α-methyldopa
dl-MK 485
NSC 92521
D,L-Carbidopa
S(-)-α-Hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
S(-)-CARBIDOPA
(S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
Lodosyn
Lodysin
Menesit
Neo-Dopaston
Carbidopa
CAS Number
302-53-4
28860-95-9
EC Number
249-271-9
MDL Number
MFCD00069231
PubChem SID
24277889
24892402
162091364
PubChem CID
2563

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 3.5892224  H Acceptors
H Donor LogD (pH = 5.5) -1.3181038 
LogD (pH = 7.4) -2.5354536  Log P -1.1881938 
Molar Refractivity 68.7683 cm3 Polarizability 22.328514 Å3
Polar Surface Area 115.81 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Solubility
DMSO expand Show data source
Water expand Show data source
Apperance
Brown Solid expand Show data source
powder expand Show data source
white solid expand Show data source
Melting Point
175-178°C (dec.) expand Show data source
208°C expand Show data source
Optical Rotation
[α]26/D -13.82°, c = 0.3 in methanol(lit.) expand Show data source
Absorption Wavelength
εmax/282.5 nm, methanol 2950 expand Show data source
Storage Condition
-20°C, Protect from light expand Show data source
Hygroscopic, -20°C Freezer, Under Inert Atmosphere expand Show data source
RTECS
MW5298000 expand Show data source
MSDS Link
Download expand Show data source
Download expand Show data source
German water hazard class
3 expand Show data source
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand Show data source
Storage Temperature
-20°C expand Show data source
Gene Information
human ... DDC(1644) expand Show data source
Mechanism of Action
Dopa-decarboxylase inhibitor expand Show data source
Purity
≥98% (TLC) expand Show data source
Certificate of Analysis
Download expand Show data source
Download expand Show data source
Application(s)
Antiparkinsonian agent expand Show data source
Used in treatment of parkinsonism expand Show data source

DETAILS

DETAILS

MP Biomedicals MP Biomedicals Sigma Aldrich Sigma Aldrich TRC TRC
MP Biomedicals - 02153757 external link
Used as a Parkinson's Disease therapeutic in combination with L-DOPA.
Sigma Aldrich - C1335 external link
Biochem/physiol Actions
Peripheral inhibitor of L-aromatic amino acid decarboxylase. When co-administered with L-DOPA, it prevents extra-CNS conversion to dopamine, thereby increasing CNS concentrations of effective compounds. Selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells by increasing H2O2 in these cell lines, which are sensitive to reactive oxygen species.1
Sigma Aldrich - C126 external link
Caution
Light sensitive
Biochem/physiol Actions
Peripheral inhibitor of L-aromatic amino acid decarboxylase. When co-administered with L-DOPA, it prevents extra-CNS conversion to dopamine, thereby increasing CNS concentrations of effective compounds. Selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells by increasing H2O2 in these cell lines, which are sensitive to reactive oxygen species.1
Toronto Research Chemicals - C175915 external link
An inhibitor of aromatic amino acid decarboxylase.

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • Sletzinger, M., et al.: J. Med. Chem., 6, 101 (1963)
  • • Karady, S. et al., J.O.C., 1971, 36, 1949, (synth)
  • • Lotti, V., Adv. Neurol., 1973, 2, 91, (rev, pharmacol)
  • • Rao, S.K. et al., Adv. Neurol., 1973, 3, 73, (rev, metab, pharmacol)
  • • Falck, R.L., Drug Intell. Clin. Pharm., 1976, 10, 84, (rev)
  • • Pinder, R.M. et al., Drugs, 1976, 11, 329, (rev)
  • • Lotti, V.J. et al., Clin. Ther., 1977, 1, 66, (Sinemet)
  • • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 840
  • • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, CBQ500
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle